Business Context and Reporting Period
This Form 8-K was filed by Lion Biotechnologies, Inc. (not IOVANCE BIOTHERAPEUTICS, INC.) on November 3, 2016. The registrant is incorporated in Nevada with principal executive offices in San Carlos, CA. The filing serves as a Regulation FD disclosure regarding investor presentations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate presentation and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the intent to make presentations to current and prospective investors.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to make presentations to investors. A copy of the presentation is included as Exhibit 99.1.
- Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is not deemed "filed" for any purpose and shall not be incorporated by reference into any Securities Act or Exchange Act filings.
- Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K.
Investor Verification Checklist
- Verify the correct registrant name is Lion Biotechnologies, Inc., as the input metadata referenced IOVANCE BIOTHERAPEUTICS, INC.
- Review Exhibit 99.1 (Corporate Presentation) for specific business updates, as the 8-K text itself contains no operational details.
- Note that the presentation materials are not legally "filed" and cannot be relied upon as incorporated by reference in other SEC filings.
- Confirm the date of the earliest event reported is November 3, 2016.